Sexual dysfunction in women with migraines: a systematic review
Abstract
Abstract Purpose The goal of this systematic review is to establish the prevalence of sexual dysfunction among women with migraines. Secondarily, this review explores factors contributing to the relationship between sexual dysfunction and migraine in women. Methods A thorough search of PubMed from inception to June 17, 2024 was completed. Search terms included migraine related terms and sexual dysfunction outcome related terms. Two independent reviewers assessed articles for relevance and extracted information from selected articles. Results In this review, a thorough search of the MEDLINE and CINAHL databases yielded 16 studies with 1,715 participants. The results demonstrated prevalence rates of sexual dysfunction in female migraine patients between 22.6% and 90%. There was a pooled prevalence of 69% (95% CI 61–77%) with substantial between-study heterogeneity (I 2 = 78.73%). Prevalence rates of sexual dysfunction were higher in women with migraine than in healthy controls. Migraine characteristics, such as duration, frequency, and pain are associated with sexual dysfunction. A bi-directional correlation exists between psychological factors, such as anxiety and depression, and sexual dysfunction in patients with migraine. Conclusion Migraines are associated with profound impacts on health-related quality of life. Sexual dysfunction is commonly associated with migraine in female patients, indicating that clinicians should routinely screen for sexual dysfunction in this…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 1,715 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.